Two Point Capital Management Inc. Has $2.91 Million Stake in Amdocs Limited (NASDAQ:DOX)

Two Point Capital Management Inc. grew its holdings in Amdocs Limited (NASDAQ:DOX) by 0.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 33,116 shares of the technology company’s stock after acquiring an additional 260 shares during the quarter. Amdocs accounts for about 1.3% of Two Point Capital Management Inc.’s investment portfolio, making the stock its 21st largest holding. Two Point Capital Management Inc.’s holdings in Amdocs were worth $2,911,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the business. New York State Teachers Retirement System bought a new position in shares of Amdocs during the fourth quarter worth about $930,000. Diversified Trust Co acquired a new position in Amdocs during the fourth quarter valued at approximately $3,957,000. Wedge Capital Management L L P NC boosted its position in Amdocs by 9.3% during the fourth quarter. Wedge Capital Management L L P NC now owns 917,808 shares of the technology company’s stock valued at $80,666,000 after purchasing an additional 77,833 shares during the last quarter. Legato Capital Management LLC acquired a new position in Amdocs during the fourth quarter valued at approximately $2,260,000. Finally, Xponance Inc. boosted its position in Amdocs by 8.4% during the third quarter. Xponance Inc. now owns 4,469 shares of the technology company’s stock valued at $378,000 after purchasing an additional 348 shares during the last quarter. 92.02% of the stock is currently owned by institutional investors.

Amdocs Stock Performance

NASDAQ:DOX traded down $0.62 during mid-day trading on Friday, hitting $85.02. 338,051 shares of the stock were exchanged, compared to its average volume of 646,009. The stock has a market capitalization of $9.99 billion, a price-to-earnings ratio of 18.25, a price-to-earnings-growth ratio of 1.41 and a beta of 0.69. The firm’s 50-day simple moving average is $89.75 and its 200 day simple moving average is $87.31. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.29 and a current ratio of 1.29. Amdocs Limited has a fifty-two week low of $78.38 and a fifty-two week high of $99.75.

Amdocs (NASDAQ:DOX) last released its quarterly earnings results on Tuesday, February 6th. The technology company reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.16. The business had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.24 billion. Amdocs had a return on equity of 17.79% and a net margin of 11.30%. The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period last year, the firm posted $1.33 EPS. As a group, equities analysts anticipate that Amdocs Limited will post 5.87 EPS for the current fiscal year.

Amdocs Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be paid a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a yield of 2.25%. The ex-dividend date of this dividend is Wednesday, March 27th. This is a positive change from Amdocs’s previous quarterly dividend of $0.44. Amdocs’s dividend payout ratio (DPR) is 41.11%.

Wall Street Analyst Weigh In

DOX has been the subject of several recent research reports. Citigroup increased their price target on Amdocs from $96.00 to $104.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. StockNews.com cut Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Friday, March 15th. Finally, Barclays raised their price objective on Amdocs from $105.00 to $115.00 and gave the company an “overweight” rating in a research report on Thursday, February 8th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, Amdocs presently has an average rating of “Buy” and an average price target of $108.60.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.